Oncolytics Biotech Inc. is developing pelareorep, a safe and well-tolerated intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments.
View Top Employees from Oncolytics Biotech Inc.Website | http://www.oncolyticsbiotech.com/ |
Ticker | ONC |
Revenue | $124000 |
Employees | 36 (33 on RocketReach) |
Founded | 1998 |
Address | 322 – 11th Avenue SW, 804, Calgary, Alberta T2R 0C5, CA |
Phone | (403) 670-7377 |
Fax | (403) 283-0858 |
Technologies |
JavaScript,
HTML,
PHP
+19 more
(view full list)
|
Industry | Biotechnology, Medical Testing & Clinical Laboratories, Pharmaceuticals, Healthcare, Science and Engineering, Health Care, Manufacturing, Medical, Therapeutics, Wellness |
Web Rank | 2 Million |
Keywords | Oncolytics Biotech, Oncolytics Biotech, Inc., Oncy Co, Biotech Calgary, Oncolytics Biotech Reolysin |
Competitors | DNAtrix, Genelux, MIS.CARBONART, Neotropix, TYME Technologies Inc. |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 54199 Companies, NAICS Code 5419 Companies |
Looking for a particular Oncolytics Biotech Inc. employee's phone or email?
The Oncolytics Biotech Inc. annual revenue was $124000 in 2024.
Matt Coffey is the President and Chief Executive Officer of Oncolytics Biotech Inc..
33 people are employed at Oncolytics Biotech Inc..
Oncolytics Biotech Inc. is based in Calgary, Alberta.
The NAICS codes for Oncolytics Biotech Inc. are [541, 54, 54199, 5419].
The SIC codes for Oncolytics Biotech Inc. are [87, 873].